Bayer | BAYN - Operating Profit


Bayer reported EUR827M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Air Liquide EUR 2.89B 48.7M Jun/2026
Akzo Nobel EUR 251M 3M Jun/2026
Alcon AG USD 44M 253M Jun/2026
Amarin USD -2.26M 564K Dec/2025
Arkema EUR 187.7M 106.8M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
BASF EUR 1.43B 31M Jun/2026
Bayer EUR 827M 2.7B Jun/2026
Beiersdorf EUR 504M 312M Dec/2025
Corteva USD 1.95B 795.92M Jun/2026
Covestro EUR -324M 5.72B Dec/2025
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 537.27M 269.27M Jun/2026
Genmab DKK 407M 182M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Henkel EUR 1.64B 220M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Johnson Matthey GBP 198M 56M Jun/2026
Linde USD 2.38B 129M Mar/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.1B 51M Jun/2026
Novartis USD 4.75B 515M Jun/2026
Nutrien USD 1.85B 1.48B Jun/2026
Philips EUR 610M 308M Jun/2026
PPG Industries USD 636M 111M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
SAP EUR 2.64B 11.13B Jun/2026
Solvay EUR 73M 45M Jun/2026
UCB EUR 1.29B 571M Dec/2025
Umicore EUR -13.2B 13.91B Jun/2026
Vinci EUR 4.01B 2.04B Jun/2026